Eventually, the downregulation of p-AKT and MMP-9 contributing to the inhibition of cell migration and invasion as well as an enhancement of the drug accumulation in the tumor and lungs were observed after the DTX/Qu-loaded PP-HA/NPs administration suggesting a promising potential in the treatment of metastatic breast cancer [11]. The gene discussed is AKT1; the disease is neoplasm.